LaPrincess Allen

LaPrincess Allen serves as the primary procurement lead within the FDA Office of Acquisition and Grant Services, driving the acquisition of high-precision analytical instrumentation and specialized research support services critical to the agency’s regulatory science mission. She manages complex contracting actions to sustain laboratory infrastructure, ensure the reliability of scientific data, and enable the FDA’s oversight of drug safety, medical devices, and biological products. Her portfolio centers on technical procurement requiring deep scientific and engineering expertise, particularly in the procurement of calibrated analytical systems, clinical research support, and toxicological evaluation services essential to regulatory decision-making. Allen maintains consistent partnerships with niche scientific service providers, including Tranquil Clinical and Research Consulting Services LLC, Toxicologic Pathology Associates Inc., and Progenics Pharmaceuticals Inc., reflecting a preference for specialized vendors with proven capabilities in regulatory-compliant research and analytical testing. These relationships are characterized by long-term, performance-based engagements that prioritize technical rigor, data integrity, and compliance with Good Laboratory Practices (GLP) and Good Clinical Practices (GCP). Her contracting approach emphasizes vendor reliability, subject matter expertise, and adherence to FDA quality standards over volume-based procurement. Allen’s procurement activity is exclusively non-set-aside, with 100% of awards issued under full and open competition, indicating a strategic focus on technical capability over socioeconomic preferences. While small business participation is not formally prioritized in her contracting patterns, she maintains a rigorous evaluation framework centered on technical merit, past performance, and regulatory compliance. Her primary procurement focus is on NAICS 334516 — Analytical Laboratory Instrument Manufacturing — encompassing mass spectrometers, chromatography systems, biosensors, and other high-end analytical equipment used in FDA laboratories. She specializes in acquiring mission-critical instrumentation that supports toxicology, pharmacokinetics, and analytical method validation, demonstrating deep domain expertise in regulatory science infrastructure and scientific equipment procurement.